Promoter hypermethylation of HOXA9 was found in oral [35, 36], breast [37], ovarian [38], bladder [39], and non-small cell lung cancer [40] in which HOXA9 functions as a tumor suppressor gene. The gene discussed is HOXA9; the disease is neoplasm.